Abstract The Infectious Diseases Society of America and the American Association for the
Study of Liver Diseases have collaboratively developed evidence-based guidance …

HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …

WHO estimates reveal that the global prevalence of viral hepatitis may be as high as 500
million, with an annual mortality rate of up to 1.3 million individuals. The majority of this …

Web Annexes Page 1 Page | i GUIDELINES ON HEPATITIS B AND C TESTING February 2017
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …

The treatment of hepatitis C has become safer, better tolerated and more effective owing to
the availability of direct-acting antivirals for nearly all patients; this guideline advocates …

Background Population‐level monitoring of hepatitis C virus (HCV) infected people across
cascades of care identifies gaps in access and engagement in care and treatment. We …

Testing and diagnosis of hepatitis C virus (HCV) infection is the gateway for access to both
treatment and prevention services, and crucial for an effective hepatitis epidemic response …

Background & Aims In Europe, hepatitis C virus (HCV) screening still targets people at high
risk of infection. We aim to determine the cost-effectiveness of expanded HCV screening in …

Abstract Background and Aims Cost‐effective screening strategies are needed to make
hepatitis C virus (HCV) elimination a reality. We determined if birth cohort screening is cost …

Methods The task force is an independent panel of clinicians and methodologists that makes
recommendations about clinical interventions aimed at primary and secondary prevention …